|
Литература: 1. Guiot HFI, Fibbe WE, Wout JW van't. Risk factors for fungal infection in patients with malignant hematological disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994:18:525-32. 2. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engi J Med 1984:311:354-8. 3. Brooks RG. Prospective study of Candida endophtalmitis in hospitalized patients with candidemia. Arch Intern Med 1989:149:2226-8. 4. Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome [review]. Ann Intern Med 1988:18:88-100. 5. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engi J Med 1991:324:654-62. 6. ZugerA, Louie E, Hoizman RS, SimberkoffMS, Rahall JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986:104:234-40. 7. Supparatpinyo К, Khamwan С, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillum marneffei infection in southeast Asia. Lancet 1994:344:110-3. Взято из Ned Tijdschr Geneeskd 1995:139(28): 1430-6 с разрешения главной редакции и авторов
|